Zentrum Fuer Ambulante Pneumologische Forschung Marburg GbR

At Zentrum Fuer Ambulante Pneumologische Forschung Marburg GbR, most studies focus on respiratory tract diseases, especially asthma and chronic obstructive pulmonary disease (COPD). The trials are designed to test new treatments, compare them with placebo or standard care, and better understand how to reduce flare-ups and improve day-to-day breathing control.

• Uncontrolled and moderate-to-severe asthma
• COPD ranging from moderate to very severe disease
• Refractory chronic cough and unexplained chronic cough

Research at this site also includes evaluating treatment effectiveness and therapeutic equivalence, with a strong emphasis on improving symptom control, lowering exacerbation risk, and supporting better long-term respiratory outcomes.

The site also contributes to trials in immune system phenomena, reflecting interest in how inflammation and immune pathways influence chronic lung conditions. These studies aim to assess whether targeted therapies can help patients whose asthma or COPD remains difficult to manage.

• Inflammation-related treatment approaches in asthma
• Immune-focused strategies for COPD exacerbation prevention
• Novel therapies for chronic airway symptoms linked to immune activity

Overall, the research agenda combines respiratory and immune-focused science to explore new ways of reducing inflammation, easing symptoms, and improving quality of life for people with persistent lung disease.